April 21, 2016 – The St. Paul’s Foundation, in collaboration with the BC Centre for Excellence in HIV/AIDS (BCCfE), the BC Centre for Disease Control (BCCDC), the Vancouver Coastal Health, and the University of British Columbia, has been given $5 million for a research study on how to reduce new infections of hepatitis C in BC.
The funding will be used to “help those at increased risk of re-infection with hepatitis C, by focusing on engagement with the health system, and it will help to evaluate the health outcomes with our current treatment regimens,” stated Health Minister Terry Lake at the morning announcement in Vancouver.
The research will focus on “individuals in Vancouver who have been successfully cured of hepatitis C, but who have been identified as at increased risk of re-infection. It will also evaluate the impact and outcomes of current hepatitis C treatments, and identify the next steps required to optimize treatment outcomes in B.C.” (BCCfE)
This hepatitis C research funding announcement was made today by the Health Minister Terry Lake and BC Centre for Excellence in HIV/AIDS (BCCfE)’s director Dr. Julio Montaner.
At the announcement, Dr. Mel Krajden, medical lead for hepatitis at the BC Centre for Disease Control, pointed out that “By understanding how to optimize treatment outcomes, we can maximize the individual and societal impact of these very promising therapies.” (BCCfE)
Links to More Information about the Announcement
- Link to the full Press Release posted by the BC Centre for Excellence in HIV/AIDS
- Link to The Vancouver Sun article entitled AIDS expert to head $5-million research efforts on hepatitis C, includes quotes from Daryl Luster, president of PHCN
- Link to CBC article entitled Hepatitis C research in B.C. given $5M boost
Information from BCCfE’s press release